Connexins: Indicators for hormonal and blastocyst-mediated endometrial differentiation

The Endometrium: Molecular, Cellular and Clinical Perspectives, Second Edition

Volumn , Issue , 2008, Pages 319-330

  Grümmer, Ruth ^a   Winterhager, Elike ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 70349412599     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (93)

1. Wilcox AJ, Weinberg CR, O’Connor JF et al. Incidence of early loss of pregnancy. N Engl J Med 1988; 319(4): 189-94.
2. Barash A, Dekel N, Fieldust S et al. Local injury to the endometrium doubles the incidence of successful pregnancies in patients undergoing in vitro fertilization. Fertil Steril 2003; 79(6): 1317-22.
3. Schlafke S, Welsh AO, Enders AC. Penetration of the basal lamina of the uterine luminal epithelium during implantation in the rat. Anat Rec 1985; 212: 47-56.
4. Denker HW. Implantation: a cell biological paradox. J Exp Zool 1993; 266(6): 541-58.
5. Psychoyos A. Hormonal control of ovoimplantation. Vitam Horm 1973; 31: 201-56.
6. Carson DD, Bagchi I, Dey SK et al. Embryo implantation. Dev Biol 2000; 223(2): 217-37.
7. Dey SK, Lim H, Das SK et al. Molecular cues to implantation. Endocr Rev 2004; 25(3): 341-73.
8. Enders AC, Schlafke S. Cytological aspects of trophoblast- uterine interaction in early implantation. Am J Anat 1969; 125(1): 1-29.
9. Tranguch S, Daikoku T, Guo Y et al. Molecular complexity in establishing uterine receptivity and implantation. Cell Mol Life Sci 2005; 62(17): 1964-73.
10. Dimitriadis E, White CA, Jones RL et al. Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update 2005; 11(6): 613-30.
11. Psychoyos A, Bitton V. [Chronologic aspects of the anti- implantation effect of the presence of a thread in the uterus of the rat]. C R Seances Soc Biol Fil 1966; 160(2): 229-32. [in French]
12. Paria BC, Reese J, Das SK et al. Deciphering the cross-talk of implantation: advances and challenges. Science 2002; 296(5576): 2185-8.
13. Norwitz ER, Schust DJ, Fisher SJ. Implantation and the survival of early pregnancy. N Engl J Med 2001; 345(19): 1400-8.
14. Winterhager E, Brummer F, Dermietzel R et al. Gap junction formation in rabbit uterine epithelium in response to embryo recognition. Dev Biol 1988; 126(1): 203-11.
15. Winterhager E, Grummer R, Jahn E et al. Spatial and temporal expression of connexin26 and connexin43 in rat endometrium during trophoblast invasion. Dev Biol 1993; 157(2): 399-409.
16. Grümmer R, Chwalisz K, Mulholland J et al. Regulation of connexin26 and connexin43 expression in rat endometrium by ovarian steroid hormones. Biol Reprod 1994; 51(6): 1109-16.
17. Grümmer R, Traub O, Winterhager E. Gap junction connexin genes cx26 and cx43 are differentially regulated by ovarian steroid hormones in rat endometrium. Endocrinology 1999; 140(6): 2509-16.
18. Cavagna M, Mantese JC. Biomarkers of endometrial receptivity - a review. Placenta 2003; 24 (Suppl B): S39-47.
19. Carson DD, Lagow E, Thathiah A et al. Changes in gene expression during the early to mid-luteal (receptive phase) transition in human endometrium detected by high-density microarray screening. Mol Hum Reprod 2002; 8(9): 871-9.
20. Dominguez F, Remohi J, Pellicer A et al. Human endometrial receptivity: a genomic approach. Reprod Biomed Online 2003; 6(3): 332-8.
21. Kao LC, Tulac S, Lobo S et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology 2002; 143(6): 2119-38.
22. Riesewijk A, Martin J, van Os R et al. Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology. Mol Hum Reprod 2003; 9(5): 253-64.
23. Dominguez F, Pellicer A, Simon C. The chemokine connection: hormonal and embryonic regulation at the human maternal- embryonic interface - a review. Placenta 2003; 24(Suppl B): S48-55.
24. Aplin JD, Meseguer M, Simon C et al. MUC1, glycans and the cell-surface barrier to embryo implantation. Biochem Soc Trans 2001; 29(Pt 2): 153-6.
25. Willecke K, Eiberger J, Degen J et al. Structural and functional diversity of connexin genes in the mouse and human genome. Biol Chem 2002; 383(5): 725-37.
26. Söhl G, Willecke K. An update on connexin genes and their nomenclature in mouse and man. Cell Commun Adhes 2003; 10(4-6): 173-80.
27. Willecke K. Connexin and pannexin genes in the mouse and human genome. In: Winterhager E, ed. Gap Junctions in Development and Disease. Berlin: Springer, 2005: 1-12.
28. Plum A, Hallas G, Magin T et al. Unique and shared functions of different connexins in mice. Curr Biol 2000; 10(18): 1083-91.
29. Zheng-Fischhöfer Q, Ghanem A, Kim JS et al. Connexin31 cannot functionally replace connexin43 during cardiac morphogenesis in mice. J Cell Sci 2006; 119: 693-701.
30. Dang X, Doble BW, Kardami E. The carboxy-tail of connexin-43 localizes to the nucleus and inhibits cell growth. Mol Cell Biochem 2003; 242(1-2): 35-8.
31. Zhang YW, Nakayama K, Morita I. A novel route for connexin 43 to inhibit cell proliferation: negative regulation of S-phase kinaseassociated protein (Skp 2). Cancer Res 2003; 63(7): 1623-30.
32. Lampe PD, Lau AF. Regulation of gap junctions by phosphorylation of connexins. Arch Biochem Biophys 2000; 384(2): 205-15.
33. Giepmans BN, Moolenaar WH. The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein. Curr Biol 1998; 8(16): 931-4.
34. Giepmans BN, Hengeveld T, Postma FR et al. Interaction of c-Src with gap junction protein connexin-43. Role in the regulation of cell-cell communication. J Biol Chem 2001; 276(11): 8544-9.
35. Giepmans BN, Verlaan I, Moolenaar WH. Connexin-43 interactions with ZO-1 and alpha- and beta-tubulin. Cell Commun Adhes 2001; 8(4-6): 219-23.
36. Fu CT, Bechberger JF, Ozog MA et al. CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible mechanism of connexin-mediated growth suppression. J Biol Chem 2004; 279(35): 36943-50.
37. Gellhaus A, Dong X, Propson S et al. Connexin43 interacts with NOV: a possible mechanism for negative regulation of cell growth in choriocarcinoma cells. J Biol Chem 2004; 279(35): 36931-42.
38. Winterhager E, Stutenkemper R, Traub O et al. Expression of different connexin genes in rat uterus during decidualization and at term. Eur J Cell Biol 1991; 55(1): 133-42.
39. MacKenzie LW, Garfield RE. Hormonal control of gap junctions in the myometrium. Am J Physiol 1985; 248(3 Pt 1): C296-308.
40. Grümmer R, Winterhager E. Regulation of gap junction connexins in the endometrium during early pregnancy. Cell Tissue Res 1998; 293(2): 189-94.
41. Reese J, Das SK, Paria BC et al. Global gene expression analysis to identify molecular markers of uterine receptivity and embryo implantation. J Biol Chem 2001; 276(47): 44137-45.
42. Glasser SR. Biochemical and structural changes in uterine endometrial cell types following natural or artificial deciduogenic stimuli. In: Denker HW, Aplin JD, eds. Trophoblast Research 4: Trophoblast Invasion and Endometrial Receptivity. New York: Plenum Medical 1990: 377-416.
43. Finn CA, Lawn AM. Specialized junctions between decidual cells in the uterus of the pregnant mouse. J Ultrastruct Res 1967; 20(5): 321-7.
44. Kleinfeld RG, Morrow H, DeFeo VJ. Intercellular junctions between decidual cells in the growing deciduoma of the pseudopregnant rat uterus. Biol Reprod 1976; 15(5): 593-603.
45. Pauken CM, Lo CW. Nonoverlapping expression of Cx43 and Cx26 in the mouse placenta and decidua: a pattern of gap junction gene expression differing from that in the rat. Mol Reprod Dev 1995; 41(2): 195-203.
46. Grümmer R, Hewitt SW, Traub O et al. Different regulatory pathways of endometrial connexin expression: preimplantation hormonal-mediated pathway versus embryo implantation- initiated pathway. Biol Reprod 2004; 71(1): 273-81.
47. Enders AC, Schlafke S. Penetration of the uterine epithelium during implantation in the rabbit. Am J Anat 1971; 132(2): 219-30.
48. Day WE, Bowen JA, Barhoumi R et al. Endometrial connexin expression in the mare and pig: evidence for the suppression of cell-cell communication in uterine luminal epithelium. Anat Rec 1998; 251(3): 277-85.
49. Gabriel S, Winterhager E, Pfarrer C et al. Modulation of connexin expression in sheep endometrium in response to pregnancy. Placenta 2004; 25(4): 287-96.
50. Ou CW, Orsino A, Lye SJ. Expression of connexin-43 and connexin-26 in the rat myometrium during pregnancy and labor is differentially regulated by mechanical and hormonal signals. Endocrinology 1997; 138(12): 5398-407.
51. Chwalisz K, Fahrenholz F, Hackenberg M et al. The progesterone antagonist onapristone increases the effectiveness of oxytocin to produce delivery without changing the myometrial oxytocin receptor concentrations. Am J Obstet Gynecol 1991; 165(6 Pt 1): 1760-70.
52. Di WL, Lachelin GC, McGarrigle HH et al. Oestriol and oestradiol increase cell to cell communication and connexin43 protein expression in human myometrium. Mol Hum Reprod 2001; 7(7): 671-9.
53. Heikaus S, Winterhager E, Traub O, Grümmer R. Responsiveness of endometrial genes Connexin26, Connexin43, C3 and clusterin to primary estrogen, selective estrogen receptor modulators, phyto- and xenoestrogens. J Mol Endocrinol 2002; 29(2): 239-49.
54. Couse JF, Lindzey J, Grandien K et al. Tissue distribution and quantitative analysis of estrogen receptor-alpha (ERalpha) and estrogen receptor-beta (ERbeta) messenger ribonucleic acid in the wild-type and ERalpha-knockout mouse. Endocrinology 1997; 138(11): 4613-21.
55. Hiroi H, Inoue S, Watanabe T et al. Differential immunolocalization of estrogen receptor alpha and beta in rat ovary and uterus. J Mol Endocrinol 1999; 22(1): 37-44.
56. Shughrue PJ, Lane MV, Scrimo PJ et al. Comparative distribution of estrogen receptor-alpha (ER-alpha) and beta (ER-beta) mRNA in the rat pituitary, gonad, and reproductive tract. Steroids 1998; 63(10): 498-504.
57. Curtis Hewitt S, Goulding EH, Eddy EM et al. Studies using the estrogen receptor alpha knockout uterus demonstrate that implantation but not decidualization-associated signaling is estrogen dependent. Biol Reprod 2002; 67(4): 1268-77.
58. Lim H, Song H, Paria BC et al. Molecules in blastocyst implantation: uterine and embryonic perspectives. Vitam Horm 2002; 64: 43-76.
59. Salamonsen LA, Dimitriadis E, Robb L. Cytokines in implantation. Semin Reprod Med 2000; 18(3): 299-310.
60. Simon C, Moreno C, Remohi J et al. Molecular interactions between embryo and uterus in the adhesion phase of human implantation. Hum Reprod 1998; 13(Suppl 3): 219-32; discussion 233-6.
61. Pakrasi PL, Dey SK. Blastocyst is the source of prostaglandins in the implantation site in the rabbit. Prostaglandins 1982; 24(1): 73-7.
62. Gabriel HD, Jung D, Butzler C et al. Transplacental uptake of glucose is decreased in embryonic lethal connexin26-deficient mice. J Cell Biol 1998; 140(6): 1453-61.
63. Reaume AG, de Sousa PA, Kulkarni S et al. Cardiac malformation in neonatal mice lacking connexin43. Science 1995; 267(5205): 1831-4.
64. Joswig A, Gabriel HD, Kibschull M et al. Apoptosis in uterine epithelium and decidua in response to implantation: evidence for two different pathways. Reprod Biol Endocrinol 2003; 1: 44.
65. Davis DL, Bradlow HL, Wolff M et al. Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 1993; 101(5): 372-7.
66. Cotton P. Environmental estrogenic agents area of concern. JAMA 1994; 271(6): 414, 416.
67. Safe S. Endocrine disruptors and human health: is there a problem. Toxicology 2004; 205(1-2): 3-10.
68. Nass SJ, Hahm HA, Davidson NE. Breast cancer biology blossoms in the clinic. Nat Med 1998; 4(7): 761-2.
69. Overmoyer BA. The breast cancer prevention trial (P-1 study). The role of tamoxifen in preventing breast cancer. Cleve Clin J Med 1999; 66(1): 33-40.
70. Beck V, Unterrieder E, Krenn L et al. Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extracts for large scale use in hormone replacement therapy. J Steroid Biochem Mol Biol 2003; 84(2-3): 259-68.
71. Brevini TA, Zanetto SB, Cillo F. Effects of endocrine disruptors on developmental and reproductive functions. Curr Drug Targets Immune Endocr Metabol Disord 2005; 5(1): 1-10.
72. Burke C. Endometrial cancer and tamoxifen. Clin J Oncol Nurs 2005; 9(2): 247-9.
73. Assikis VJ, Jordan VC. Gynecologic effects of tamoxifen and the association with endometrial carcinoma. Int J Gynaecol Obstet 1995; 49(3): 241-57.
74. Burckhardt P. [Selective estrogen receptor modulators (SERM): new substances for hormone replacement therapy]. Schweiz Med Wochenschr 1999; 129(49): 1926-30. [in German]
75. Branca F, Lorenzetti S. Health effects of phytoestrogens. Forum Nutr 2005; 57: 100-11.
76. Jefferson WN, Padilla-Banks E, Newbold RR. Adverse effects on female development and reproduction in CD-1 mice following neonatal exposure to the phytoestrogen genistein at environmentally relevant doses. Biol Reprod 2005; 73(4): 798-806.
77. Kuiper GG, Carlsson B, Grandien K et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138(3): 863-70.
78. Hopert AC, Beyer A, Frank K et al. Characterization of estrogenicity of phytoestrogens in an endometrial-derived experimental model. Environ Health Perspect 1998; 106(9): 581-6.
79. Strunck E, Stemmann N, Hopert A et al. Relative binding affinity does not predict biological response to xenoestrogens in rat endometrial adenocarcinoma cells. J Steroid Biochem Mol Biol 2000; 74(3): 73-81.
80. Jahn E, Classen-Linke I, Kusche M et al. Expression of gap junction connexins in the human endometrium throughout the menstrual cycle. Hum Reprod 1995; 10(10): 2666-70.
81. Granot I, Dekel N, Bechor E et al. Temporal analysis of connexin43 protein and gene expression throughout the menstrual cycle in human endometrium. Fertil Steril 2000; 73(2): 381-6.
82. Saito T, Oyamada M, Yamasaki H et al. Co-ordinated expression of connexins 26 and 32 in human endometrial glandular epithelium during the reproductive cycle and the influence of hormone replacement therapy. Int J Cancer 1997; 73(4): 479-85.
83. Roberts DK, Walker NJ, Lavia LA. Ultrastructural evidence of stromal/epithelial interactions in the human endometrial cycle. Am J Obstet Gynecol 1988; 158(4): 854-61.
84. Mesnil M. Connexins and cancer. Biol Cell 2002; 94(7-8): 493-500.
85. King TJ, Fukushima LH, Yasui Y et al. Inducible expression of the gap junction protein connexin43 decreases the neoplastic potential of HT-1080 human fibrosarcoma cells in vitro and in vivo. Mol Carcinog 2002; 35(1): 29-41.
86. Dagli ML, Yamasaki H, Krutovskikh V et al. Delayed liver regeneration and increased susceptibility to chemical hepatocarcinogenesis in transgenic mice expressing a dominantnegative mutant of connexin32 only in the liver. Carcinogenesis 2004; 25(4): 483-92.
87. Temme A, Buchmann A, Gabriel HD et al. High incidence of spontaneous and chemically induced liver tumors in mice deficient for connexin32. Curr Biol 1997; 7(9): 713-16.
88. Evert M, Ott T, Temme A et al. Morphology and morphometric investigation of hepatocellular preneoplastic lesions and neoplasms in connexin32-deficient mice. Carcinogenesis 2002; 23(5): 697-703.
89. Koffler L, Roshong S, Kyu Park I et al. Growth inhibition in G(1) and altered expression of cyclin D1 and p27(kip-1)after forced connexin expression in lung and liver carcinoma cells. J Cell Biochem 2000; 79(3): 347-54.
90. Saito T, Nishimura M, Kudo R et al. Suppressed gap junctional intercellular communication in carcinogenesis of endometrium. Int J Cancer 2001; 93(3): 317-23.
91. Saito T, Tanaka R, Wataba K et al. Overexpression of estrogen receptor-alpha gene suppresses gap junctional intercellular communication in endometrial carcinoma cells. Oncogene 2004; 23(5): 1109-16.
92. Regidor PA, Regidor M, Schindler AE et al. Aberrant expression pattern of gap junction connexins in endometriotic tissues. Mol Hum Reprod 1997; 3(5): 375-81.
93. Giepmans BN. Gap junctions and connexin-interacting proteins. Cardiovasc Res 2004; 62(2): 233-45.